Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
26
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Yi Miyoko Christina | Chief Operations Officer | 9 | $0 | $0 | 2023-04-27 |
| Chauche Thierry | Chief Financial Officer | 6 | $0 | $0 | 2023-04-27 |
| King-Jones Heidy | Chief Legal Officer | 11 | $0 | $0 | 2023-04-27 |
| Hoitt Jason | Chief Commercial Officer | 14 | $24.4K | $45.0K | 2023-04-27 |
| Pisano Wayne | Director | 13 | $19.0K | $0 | 2023-04-27 |
| Jenkins John Kenneth | Director | 6 | $0 | $0 | 2023-04-27 |
| Osorio Benedict | Chief Quality Officer | 8 | $0 | $0 | 2023-04-27 |
| Leon Francisco | Chief Scientific Officer | 48 | $381.0K | $3.06M | 2023-04-27 |
| Jain Rita | Director | 2 | $0 | $0 | 2023-04-27 |
| Sessa Capital IM GP, LLC | 10% Owner | 4 | $0 | $53.27M | 2023-04-27 |
| Vogel Justin | Chief Accounting Officer | 7 | $0 | $0 | 2023-04-27 |
| Palmer Ashleigh | President and CEO | 33 | $416.3K | $1.01M | 2023-04-27 |
| Ramos Eleanor | Chief Medical Officer and COO | 18 | $339.1K | $0 | 2023-04-27 |
| Wysenski Nancy | Director | 8 | $0 | $0 | 2023-04-27 |
| CATLIN AVERY W | Director | 17 | $50.3K | $0 | 2023-04-27 |
| Sessa Capital IM, L.P. | 10% Owner | 2 | $0 | $0 | 2023-04-21 |
| Sessa Capital (Master), L.P. | 10% Owner | 3 | $0 | $28.20M | 2023-04-04 |
| O'Brien Sarah | Chief People Officer | 3 | $0 | $0 | 2023-01-10 |
| Doherty Sean M | Director | 4 | $0 | $0 | 2022-05-17 |
| Bluestone Jeffrey | Director | 12 | $0 | $87.1K | 2022-05-17 |
| Drechsler Andrew T | Chief Financial Officer | 8 | $71.2K | $0 | 2021-05-12 |
| DIGIANDOMENICO ANTHONY | Director | 20 | $1.08M | $0 | 2019-12-03 |
| Johnson & Johnson Innovation - JJDC, Inc. | 10% Owner | 2 | $0 | $0 | 2018-07-19 |
| Gray Cameron | Director | 3 | $0 | $0 | 2018-07-19 |
| APPEL PETER A | 10% Owner | 2 | $3.00M | $0 | 2018-07-19 |
| MDB CAPITAL GROUP LLC | 10% Owner | 3 | $0 | $0 | 2018-07-19 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Chauche Thierry | Chief Financial Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 375,000 | — | $0 | 0 | SEC↗ |
| Chauche Thierry | Chief Financial Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 50,000 | — | $0 | 0 | SEC↗ |
| Chauche Thierry | Chief Financial Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 200,000 | — | $0 | 0 | SEC↗ |
| King-Jones Heidy | Chief Legal Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 300,000 | — | $0 | 0 | SEC↗ |
| King-Jones Heidy | Chief Legal Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 200,000 | — | $0 | 0 | SEC↗ |
| King-Jones Heidy | Chief Legal Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 145,000 | — | $0 | 0 | SEC↗ |
| King-Jones Heidy | Chief Legal Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 139,500 | — | $0 | 0 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 137,750 | — | $0 | 0 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 400,000 | — | $0 | 0 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 145,000 | — | $0 | 0 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 139,500 | — | $0 | 0 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 200,000 | — | $0 | 0 | SEC↗ |
| Osorio Benedict | Chief Quality Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 70,000 | — | $0 | 0 | SEC↗ |
| Osorio Benedict | Chief Quality Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 80,000 | — | $0 | 0 | SEC↗ |
| Osorio Benedict | Chief Quality Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 187,000 | — | $0 | 0 | SEC↗ |
| Osorio Benedict | Chief Quality Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 100,000 | — | $0 | 0 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 137,750 | — | $0 | 0 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 145,000 | — | $0 | 0 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 139,500 | — | $0 | 0 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 400,000 | — | $0 | 0 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 210,000 | — | $0 | 0 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 460,462 | — | $0 | 0 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 139,500 | — | $0 | 0 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 137,750 | — | $0 | 0 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 210,000 | — | $0 | 0 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 400,000 | — | $0 | 0 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 145,000 | — | $0 | 0 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 242,103 | — | $0 | 0 | SEC↗ |
| Vogel Justin | Chief Accounting Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 88,185 | — | $0 | 0 | SEC↗ |
| Vogel Justin | Chief Accounting Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 60,000 | — | $0 | 0 | SEC↗ |
| Vogel Justin | Chief Accounting Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 84,000 | — | $0 | 0 | SEC↗ |
| Vogel Justin | Chief Accounting Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 70,000 | — | $0 | 0 | SEC↗ |
| Vogel Justin | Chief Accounting Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 66,000 | — | $0 | 0 | SEC↗ |
| Vogel Justin | Chief Accounting Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 45,000 | — | $0 | 0 | SEC↗ |
| Yi Miyoko Christina | Chief Operations Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 300,000 | — | $0 | 0 | SEC↗ |
| Yi Miyoko Christina | Chief Operations Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 50,000 | — | $0 | 0 | SEC↗ |
| Yi Miyoko Christina | Chief Operations Officer | D To issuer deriv | 2023-04-27 | 2023-04-27 | 187,000 | — | $0 | 0 | SEC↗ |
| CATLIN AVERY W | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 128,981 | — | $0 | 0 | SEC↗ |
| CATLIN AVERY W | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 22,200 | — | $0 | 0 | SEC↗ |
| CATLIN AVERY W | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 23,000 | — | $0 | 0 | SEC↗ |
| CATLIN AVERY W | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 33,000 | — | $0 | 0 | SEC↗ |
| CATLIN AVERY W | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 24,000 | — | $0 | 0 | SEC↗ |
| Jain Rita | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 66,000 | — | $0 | 0 | SEC↗ |
| Jenkins John Kenneth | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 128,981 | — | $0 | 0 | SEC↗ |
| Jenkins John Kenneth | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 33,000 | — | $0 | 0 | SEC↗ |
| Jenkins John Kenneth | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 23,000 | — | $0 | 0 | SEC↗ |
| Palmer Ashleigh | Director and CEO | D To issuer deriv | 2023-04-27 | 2023-04-27 | 360,000 | — | $0 | 0 | SEC↗ |
| Palmer Ashleigh | Director and CEO | D To issuer deriv | 2023-04-27 | 2023-04-27 | 700,000 | — | $0 | 0 | SEC↗ |
| Palmer Ashleigh | Director and CEO | D To issuer deriv | 2023-04-27 | 2023-04-27 | 400,000 | — | $0 | 0 | SEC↗ |
| Palmer Ashleigh | Director and CEO | D To issuer deriv | 2023-04-27 | 2023-04-27 | 441,720 | — | $0 | 0 | SEC↗ |
| Palmer Ashleigh | Director and CEO | D To issuer deriv | 2023-04-27 | 2023-04-27 | 139,500 | — | $0 | 0 | SEC↗ |
| Palmer Ashleigh | Director and CEO | D To issuer deriv | 2023-04-27 | 2023-04-27 | 137,750 | — | $0 | 0 | SEC↗ |
| Pisano Wayne | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 128,981 | — | $0 | 0 | SEC↗ |
| Pisano Wayne | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 33,000 | — | $0 | 0 | SEC↗ |
| Pisano Wayne | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 23,000 | — | $0 | 0 | SEC↗ |
| Pisano Wayne | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 22,200 | — | $0 | 0 | SEC↗ |
| Pisano Wayne | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 24,000 | — | $0 | 0 | SEC↗ |
| Wysenski Nancy | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 128,981 | — | $0 | 0 | SEC↗ |
| Wysenski Nancy | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 33,000 | — | $0 | 0 | SEC↗ |
| Wysenski Nancy | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 23,000 | — | $0 | 0 | SEC↗ |
| Wysenski Nancy | Director | D To issuer deriv | 2023-04-27 | 2023-04-27 | 22,200 | — | $0 | 0 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | U Tender | 2023-04-27 | 2023-04-27 | 70,000 | — | $0 | 0 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | U Tender | 2023-04-27 | 2023-04-27 | 1,000,000 | — | $0 | 0 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | U Tender | 2023-04-27 | 2023-04-27 | 1,500,000 | — | $0 | 0 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | U Tender | 2023-04-27 | 2023-04-27 | 73,000 | — | $0 | 0 | SEC↗ |
| CATLIN AVERY W | Director | U Tender | 2023-04-27 | 2023-04-27 | 10,000 | — | $0 | 0 | SEC↗ |
| CATLIN AVERY W | Director | U Tender | 2023-04-27 | 2023-04-27 | 10,000 | — | $0 | 0 | SEC↗ |
| Palmer Ashleigh | Director and CEO | U Tender | 2023-04-27 | 2023-04-27 | 2,570,050 | — | $0 | 0 | SEC↗ |
| Pisano Wayne | Director | U Tender | 2023-04-27 | 2023-04-27 | 7,500 | — | $0 | 0 | SEC↗ |
| Sessa Capital IM GP, LLC | 10% Owner | U Tender | 2023-04-27 | 2023-04-28 | 15,567,497 | — | $0 | 0 | SEC↗ |
| Sessa Capital IM, L.P. | 10% Owner | G Gift | 2023-04-21 | 2023-04-24 | 224,617 | — | $0 | 0 | SEC↗ |
| Sessa Capital IM, L.P. | 10% Owner | G Gift | 2023-04-20 | 2023-04-24 | 202,314 | — | $0 | 224,617 | SEC↗ |
| Sessa Capital IM GP, LLC | 10% Owner | X Exercise deriv | 2023-04-14 | 2023-04-18 | 8,879,023 | — | $0 | 0 | SEC↗ |
| Sessa Capital IM GP, LLC | 10% Owner | X Exercise | 2023-04-14 | 2023-04-18 | 8,879,023 | $6.00 | $53.27M | 17,758,046 | SEC↗ |
| Sessa Capital IM GP, LLC | 10% Owner | S Sale | 2023-04-14 | 2023-04-18 | 2,190,549 | $24.32 | $53.27M | 15,567,497 | SEC↗ |
| CATLIN AVERY W | Director | G Gift | 2023-04-13 | 2023-04-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CATLIN AVERY W | Director | G Gift | 2023-04-13 | 2023-04-14 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | G Gift | 2023-04-13 | 2023-04-14 | 1,500,000 | — | $0 | 73,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | G Gift | 2023-04-13 | 2023-04-14 | 1,500,000 | — | $0 | 73,000 | SEC↗ |
| Sessa Capital (Master), L.P. | 10% Owner | G Gift | 2023-04-04 | 2023-04-04 | 218,651 | — | $0 | 426,931 | SEC↗ |
| Sessa Capital (Master), L.P. | 10% Owner | J Other | 2023-03-31 | 2023-04-04 | 3,000,000 | — | $0 | 8,879,023 | SEC↗ |
| Palmer Ashleigh | Director and CEO | M Exercise deriv | 2023-02-13 | 2023-02-14 | 25,835 | — | $0 | 441,720 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise deriv | 2023-02-13 | 2023-02-14 | 25,985 | — | $0 | 242,103 | SEC↗ |
| Palmer Ashleigh | Director and CEO | S Sale | 2023-02-13 | 2023-02-14 | 25,835 | $10.04 | $259.4K | 2,570,050 | SEC↗ |
| Palmer Ashleigh | Director and CEO | M Exercise | 2023-02-13 | 2023-02-14 | 25,835 | $2.50 | $64.6K | 2,595,885 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise | 2023-02-13 | 2023-02-14 | 25,985 | $2.50 | $65.0K | 1,598,985 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | S Sale | 2023-02-13 | 2023-02-14 | 25,985 | $10.04 | $260.9K | 1,573,000 | SEC↗ |
| Palmer Ashleigh | Director and CEO | M Exercise deriv | 2023-02-10 | 2023-02-14 | 50,000 | — | $0 | 467,555 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise deriv | 2023-02-10 | 2023-02-14 | 50,000 | — | $0 | 268,088 | SEC↗ |
| Palmer Ashleigh | Director and CEO | S Sale | 2023-02-10 | 2023-02-14 | 50,000 | $10.11 | $505.5K | 2,570,050 | SEC↗ |
| Palmer Ashleigh | Director and CEO | M Exercise | 2023-02-10 | 2023-02-14 | 50,000 | $2.50 | $125.0K | 2,620,050 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | S Sale | 2023-02-10 | 2023-02-14 | 4,500 | $10.00 | $45.0K | 0 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise | 2023-02-10 | 2023-02-14 | 50,000 | $2.50 | $125.0K | 1,623,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | S Sale | 2023-02-10 | 2023-02-14 | 50,000 | $10.11 | $505.5K | 1,573,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise deriv | 2023-01-18 | 2023-01-20 | 24,015 | — | $0 | 318,088 | SEC↗ |
| Palmer Ashleigh | Director and CEO | M Exercise deriv | 2023-01-18 | 2023-01-20 | 24,165 | — | $0 | 517,555 | SEC↗ |
| Sessa Capital (Master), L.P. | 10% Owner | S Sale | 2023-01-18 | 2023-01-20 | 3,000,000 | $9.40 | $28.20M | 11,879,023 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise | 2023-01-18 | 2023-01-20 | 24,015 | $2.50 | $60.0K | 1,597,015 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | S Sale | 2023-01-18 | 2023-01-20 | 24,015 | $10.27 | $246.6K | 1,573,000 | SEC↗ |
| Palmer Ashleigh | Director and CEO | M Exercise | 2023-01-18 | 2023-01-20 | 24,165 | $2.50 | $60.4K | 2,594,215 | SEC↗ |
| Palmer Ashleigh | Director and CEO | S Sale | 2023-01-18 | 2023-01-20 | 24,165 | $10.27 | $248.2K | 2,570,050 | SEC↗ |
| Palmer Ashleigh | Director and CEO | A Award deriv | 2023-01-17 | 2023-01-18 | 700,000 | — | $0 | 700,000 | SEC↗ |
| Chauche Thierry | Chief Financial Officer | A Award deriv | 2023-01-10 | 2023-01-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | A Award deriv | 2023-01-10 | 2023-01-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| King-Jones Heidy | Chief Legal Officer | A Award deriv | 2023-01-10 | 2023-01-11 | 200,000 | — | $0 | 200,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | A Award deriv | 2023-01-10 | 2023-01-11 | 210,000 | — | $0 | 210,000 | SEC↗ |
| O'Brien Sarah | Chief People Officer | A Award deriv | 2023-01-10 | 2023-01-11 | 8,000 | — | $0 | 108,000 | SEC↗ |
| O'Brien Sarah | Chief People Officer | A Award deriv | 2023-01-10 | 2023-01-11 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Osorio Benedict | Chief Quality Officer | A Award deriv | 2023-01-10 | 2023-01-11 | 187,000 | — | $0 | 187,000 | SEC↗ |
| Yi Miyoko Christina | Chief Operations Officer | A Award deriv | 2023-01-10 | 2023-01-11 | 21,000 | — | $0 | 222,000 | SEC↗ |
| Yi Miyoko Christina | Chief Operations Officer | A Award deriv | 2023-01-10 | 2023-01-11 | 187,000 | — | $0 | 187,000 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | A Award deriv | 2023-01-10 | 2023-01-11 | 210,000 | — | $0 | 210,000 | SEC↗ |
| Vogel Justin | Chief Accounting Officer | A Award deriv | 2023-01-10 | 2023-01-11 | 84,000 | — | $0 | 84,000 | SEC↗ |
| Jain Rita | Director | A Award deriv | 2023-01-03 | 2023-01-05 | 66,000 | — | $0 | 66,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise deriv | 2022-12-29 | 2022-12-30 | 187,000 | — | $0 | 342,103 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | S Sale | 2022-12-29 | 2022-12-30 | 187,000 | $10.26 | $1.92M | 1,573,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise | 2022-12-29 | 2022-12-30 | 187,000 | $2.50 | $467.5K | 1,760,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise deriv | 2022-12-27 | 2022-12-29 | 10,674 | — | $0 | 529,103 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | S Sale | 2022-12-27 | 2022-12-29 | 10,674 | $10.00 | $106.7K | 1,573,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise | 2022-12-27 | 2022-12-29 | 10,674 | $2.50 | $26.7K | 1,583,674 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise deriv | 2022-12-23 | 2022-12-27 | 375 | — | $0 | 539,777 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise | 2022-12-23 | 2022-12-27 | 375 | $2.50 | $938 | 1,573,375 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | S Sale | 2022-12-23 | 2022-12-27 | 375 | $10.00 | $3.8K | 1,573,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise deriv | 2022-12-22 | 2022-12-27 | 1,568 | — | $0 | 540,152 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | S Sale | 2022-12-22 | 2022-12-27 | 1,568 | $10.00 | $15.7K | 1,573,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | M Exercise | 2022-12-22 | 2022-12-27 | 1,568 | $2.50 | $3.9K | 1,574,568 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | A Award deriv | 2022-12-08 | 2022-12-09 | 120,000 | — | $0 | 340,000 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | A Award deriv | 2022-12-08 | 2022-12-09 | 20,663 | — | $0 | 75,763 | SEC↗ |
| Palmer Ashleigh | Director and CEO | A Award deriv | 2022-12-08 | 2022-12-09 | 20,663 | — | $0 | 75,763 | SEC↗ |
| Yi Miyoko Christina | Chief Operations Officer | A Award deriv | 2022-12-08 | 2022-12-09 | 6,000 | — | $0 | 201,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | A Award deriv | 2022-12-08 | 2022-12-09 | 20,663 | — | $0 | 75,763 | SEC↗ |
| Osorio Benedict | Chief Quality Officer | A Award deriv | 2022-12-08 | 2022-12-09 | 18,000 | — | $0 | 79,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | A Award deriv | 2022-11-22 | 2022-11-23 | 80,000 | — | $0 | 400,000 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | A Award deriv | 2022-11-22 | 2022-11-23 | 80,000 | — | $0 | 400,000 | SEC↗ |
| King-Jones Heidy | Chief Legal Officer | A Award deriv | 2022-11-22 | 2022-11-23 | 90,000 | — | $0 | 300,000 | SEC↗ |
| Palmer Ashleigh | Director and CEO | A Award deriv | 2022-11-22 | 2022-11-23 | 80,000 | — | $0 | 400,000 | SEC↗ |
| Yi Miyoko Christina | Chief Operations Officer | A Award deriv | 2022-11-22 | 2022-11-23 | 45,000 | — | $0 | 195,000 | SEC↗ |
| O'Brien Sarah | Chief People Officer | A Award deriv | 2022-09-15 | 2022-09-19 | 100,000 | — | $0 | 100,000 | SEC↗ |
| Bluestone Jeffrey | Director | A Award deriv | 2022-05-17 | 2022-05-18 | 33,000 | — | $0 | 33,000 | SEC↗ |
| CATLIN AVERY W | Director | A Award deriv | 2022-05-17 | 2022-05-18 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Doherty Sean M | Director | A Award deriv | 2022-05-17 | 2022-05-18 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Osorio Benedict | Chief Quality Officer | A Award deriv | 2022-05-17 | 2022-05-18 | 9,000 | — | $0 | 61,000 | SEC↗ |
| Jenkins John Kenneth | Director | A Award deriv | 2022-05-17 | 2022-05-18 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Pisano Wayne | Director | A Award deriv | 2022-05-17 | 2022-05-18 | 33,000 | — | $0 | 33,000 | SEC↗ |
| Wysenski Nancy | Director | A Award deriv | 2022-05-17 | 2022-05-18 | 33,000 | — | $0 | 33,000 | SEC↗ |
| King-Jones Heidy | Chief Legal Officer | A Award deriv | 2022-03-22 | 2022-03-24 | 60,000 | — | $0 | 210,000 | SEC↗ |
| Palmer Ashleigh | Director and CEO | A Award deriv | 2022-01-19 | 2022-01-20 | 360,000 | — | $0 | 360,000 | SEC↗ |
| Chauche Thierry | Chief Financial Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| Osorio Benedict | Chief Quality Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 80,000 | — | $0 | 80,000 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 145,000 | — | $0 | 145,000 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 145,000 | — | $0 | 145,000 | SEC↗ |
| Yi Miyoko Christina | Chief Operations Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| King-Jones Heidy | Chief Legal Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 145,000 | — | $0 | 145,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | A Award deriv | 2022-01-18 | 2022-01-20 | 145,000 | — | $0 | 145,000 | SEC↗ |
| Yi Miyoko Christina | Chief Operations Officer | A Award deriv | 2021-12-16 | 2021-12-20 | 150,000 | — | $0 | 150,000 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | P Buy | 2021-12-03 | 2021-12-06 | 5,201 | $6.49 | $33.8K | 70,000 | SEC↗ |
| Chauche Thierry | Chief Financial Officer | A Award deriv | 2021-12-01 | 2021-12-01 | 187,500 | — | $0 | 187,500 | SEC↗ |
| Palmer Ashleigh | Director and CEO | P Buy | 2021-11-30 | 2021-12-01 | 3,750 | $6.66 | $25.0K | 2,570,050 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | P Buy | 2021-11-24 | 2021-11-29 | 5,550 | $7.24 | $40.2K | 2,573,000 | SEC↗ |
| King-Jones Heidy | Chief Legal Officer | A Award deriv | 2021-08-03 | 2021-08-05 | 30,000 | — | $0 | 150,000 | SEC↗ |
| Drechsler Andrew T | Chief Financial Officer | A Award deriv | 2021-05-12 | 2021-05-14 | 139,500 | — | $0 | 139,500 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | A Award deriv | 2021-05-12 | 2021-05-14 | 139,500 | — | $0 | 139,500 | SEC↗ |
| King-Jones Heidy | Chief Legal Officer | A Award deriv | 2021-05-12 | 2021-05-14 | 139,500 | — | $0 | 139,500 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | A Award deriv | 2021-05-12 | 2021-05-14 | 139,500 | — | $0 | 139,500 | SEC↗ |
| Bluestone Jeffrey | Director | A Award deriv | 2021-05-12 | 2021-05-14 | 23,000 | — | $0 | 23,000 | SEC↗ |
| Palmer Ashleigh | Director and CEO | A Award deriv | 2021-05-12 | 2021-05-14 | 139,500 | — | $0 | 139,500 | SEC↗ |
| CATLIN AVERY W | Director | A Award deriv | 2021-05-12 | 2021-05-14 | 23,000 | — | $0 | 23,000 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | A Award deriv | 2021-05-12 | 2021-05-14 | 139,500 | — | $0 | 139,500 | SEC↗ |
| Doherty Sean M | Director | A Award deriv | 2021-05-12 | 2021-05-14 | 23,000 | — | $0 | 23,000 | SEC↗ |
| Jenkins John Kenneth | Director | A Award deriv | 2021-05-12 | 2021-05-14 | 23,000 | — | $0 | 23,000 | SEC↗ |
| Pisano Wayne | Director | A Award deriv | 2021-05-12 | 2021-05-14 | 23,000 | — | $0 | 23,000 | SEC↗ |
| Wysenski Nancy | Director | A Award deriv | 2021-05-12 | 2021-05-14 | 23,000 | — | $0 | 23,000 | SEC↗ |
| Drechsler Andrew T | Chief Financial Officer | P Buy | 2020-09-02 | 2020-09-02 | 2,000 | $11.72 | $23.4K | 20,000 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | P Buy | 2020-09-02 | 2020-09-02 | 299 | $12.06 | $3.6K | 64,799 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | P Buy | 2020-08-21 | 2020-08-21 | 2,000 | $13.35 | $26.7K | 2,567,450 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | P Buy | 2020-08-20 | 2020-08-20 | 2,500 | $13.23 | $33.1K | 64,500 | SEC↗ |
| Palmer Ashleigh | President and CEO | P Buy | 2020-08-18 | 2020-08-18 | 500 | $12.69 | $6.3K | 2,566,300 | SEC↗ |
| Palmer Ashleigh | President and CEO | P Buy | 2020-08-17 | 2020-08-17 | 2,800 | $12.83 | $35.9K | 2,565,800 | SEC↗ |
| Drechsler Andrew T | Chief Financial Officer | P Buy | 2020-08-13 | 2020-08-13 | 1,750 | $13.01 | $22.8K | 18,000 | SEC↗ |
| Jenkins John Kenneth | Director | A Award deriv | 2020-08-10 | 2020-08-11 | 128,981 | — | $0 | 128,981 | SEC↗ |
| King-Jones Heidy | Chief Legal Officer | A Award deriv | 2020-08-03 | 2020-08-03 | 300,000 | — | $0 | 300,000 | SEC↗ |
| Palmer Ashleigh | President and CEO | A Award deriv | 2020-07-15 | 2020-07-16 | 137,750 | — | $0 | 137,750 | SEC↗ |
| Drechsler Andrew T | Chief Financial Officer | A Award deriv | 2020-07-15 | 2020-07-16 | 137,750 | — | $0 | 137,750 | SEC↗ |
| Doherty Sean M | Director | A Award deriv | 2020-07-15 | 2020-07-16 | 22,200 | — | $0 | 22,200 | SEC↗ |
| Wysenski Nancy | Director | A Award deriv | 2020-07-15 | 2020-07-16 | 22,200 | — | $0 | 22,200 | SEC↗ |
| Bluestone Jeffrey | Director | A Award deriv | 2020-07-15 | 2020-07-16 | 22,200 | — | $0 | 22,200 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | A Award deriv | 2020-07-15 | 2020-07-16 | 137,750 | — | $0 | 137,750 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | A Award deriv | 2020-07-15 | 2020-07-16 | 137,750 | — | $0 | 137,750 | SEC↗ |
| CATLIN AVERY W | Director | A Award deriv | 2020-07-15 | 2020-07-16 | 22,200 | — | $0 | 22,200 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer | A Award deriv | 2020-07-15 | 2020-07-16 | 137,750 | — | $0 | 137,750 | SEC↗ |
| Pisano Wayne | Director | A Award deriv | 2020-07-15 | 2020-07-16 | 22,200 | — | $0 | 22,200 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | P Buy | 2020-06-24 | 2020-06-24 | 2,000 | $15.43 | $30.9K | 2,565,450 | SEC↗ |
| Wysenski Nancy | Director | A Award deriv | 2020-05-19 | 2020-05-21 | 128,981 | — | $0 | 128,981 | SEC↗ |
| Bluestone Jeffrey | Director | M Exercise deriv | 2020-04-10 | 2020-04-14 | 32,246 | — | $0 | 96,735 | SEC↗ |
| Bluestone Jeffrey | Director | M Exercise | 2020-04-10 | 2020-04-14 | 32,246 | $2.36 | $76.1K | 39,571 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | P Buy | 2020-03-19 | 2020-03-20 | 4,500 | $5.43 | $24.4K | 4,500 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | P Buy | 2020-03-19 | 2020-03-20 | 10,000 | $5.92 | $59.2K | 2,563,450 | SEC↗ |
| Bluestone Jeffrey | Director | G Gift deriv | 2020-02-27 | 2020-04-14 | 24,000 | — | $0 | 0 | SEC↗ |
| Bluestone Jeffrey | Director | G Gift deriv | 2020-02-27 | 2020-04-14 | 24,000 | — | $0 | 0 | SEC↗ |
| Bluestone Jeffrey | Director | G Gift deriv | 2020-02-27 | 2020-04-14 | 128,981 | — | $0 | 0 | SEC↗ |
| Bluestone Jeffrey | Director | G Gift deriv | 2020-02-27 | 2020-04-14 | 128,981 | — | $0 | 0 | SEC↗ |
| Hoitt Jason | Chief Commercial Officer | A Award deriv | 2020-01-07 | 2020-01-08 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Ramos Eleanor | CMO & COO | P Buy | 2019-12-26 | 2019-12-26 | 2,000 | $14.34 | $28.7K | 62,000 | SEC↗ |
| Palmer Ashleigh | President and CEO | P Buy | 2019-12-20 | 2019-12-23 | 2,075 | $11.39 | $23.6K | 2,563,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | P Buy | 2019-12-16 | 2019-12-16 | 2,000 | $11.92 | $23.8K | 2,553,450 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | J Other | 2019-12-03 | 2019-12-06 | 342,000 | — | $0 | 520,712 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2019-09-30 | 2019-09-30 | 30,000 | $6.83 | $204.9K | 178,712 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | P Buy | 2019-09-30 | 2019-09-30 | 1,450 | $7.67 | $11.1K | 2,551,450 | SEC↗ |
| Doherty Sean M | Director | A Award deriv | 2019-09-26 | 2019-09-30 | 128,981 | — | $0 | 128,981 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2019-09-26 | 2019-09-26 | 5,000 | $8.44 | $42.2K | 148,712 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2019-09-25 | 2019-09-25 | 5,000 | $8.39 | $42.0K | 143,712 | SEC↗ |
| Palmer Ashleigh | President and CEO | P Buy | 2019-09-24 | 2019-09-24 | 3,000 | $8.38 | $25.1K | 2,560,925 | SEC↗ |
| Palmer Ashleigh | President and CEO | P Buy | 2019-08-08 | 2019-08-09 | 10,600 | $9.15 | $97.0K | 2,557,925 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | P Buy | 2019-08-08 | 2019-08-09 | 2,500 | $9.09 | $22.7K | 2,550,000 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2019-08-08 | 2019-08-09 | 10,000 | $9.09 | $90.9K | 138,712 | SEC↗ |
| Bluestone Jeffrey | Director | A Award deriv | 2019-06-24 | 2019-06-25 | 24,000 | — | $0 | 24,000 | SEC↗ |
| CATLIN AVERY W | Director | A Award deriv | 2019-06-24 | 2019-06-25 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | A Award deriv | 2019-06-24 | 2019-06-25 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Pisano Wayne | Director | A Award deriv | 2019-06-24 | 2019-06-25 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Palmer Ashleigh | President & CEO | A Award deriv | 2019-06-24 | 2019-06-25 | 400,000 | — | $0 | 400,000 | SEC↗ |
| Drechsler Andrew T | Chief Financial Officer | A Award deriv | 2019-06-24 | 2019-06-25 | 400,000 | — | $0 | 400,000 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | A Award deriv | 2019-06-24 | 2019-06-25 | 24,000 | — | $0 | 24,000 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer and CO | A Award deriv | 2019-06-24 | 2019-06-25 | 400,000 | — | $0 | 400,000 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2019-06-20 | 2019-06-20 | 10,000 | $10.96 | $109.6K | 128,712 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2019-06-18 | 2019-06-18 | 10,000 | $10.88 | $108.8K | 118,712 | SEC↗ |
| Palmer Ashleigh | President and CEO | P Buy | 2019-06-18 | 2019-06-18 | 4,000 | $10.83 | $43.3K | 2,547,325 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2019-06-17 | 2019-06-17 | 25,000 | $12.16 | $304.0K | 108,712 | SEC↗ |
| Bluestone Jeffrey | Director | S Sale | 2019-06-17 | 2019-06-17 | 7,300 | $11.93 | $87.1K | 7,325 | SEC↗ |
| Bluestone Jeffrey | Director | A Award deriv | 2019-03-27 | 2019-03-28 | 128,981 | — | $0 | 128,981 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | P Buy | 2018-12-31 | 2019-01-02 | 10,000 | $1.64 | $16.4K | 2,547,500 | SEC↗ |
| Palmer Ashleigh | President and CEO | P Buy | 2018-12-31 | 2018-12-31 | 825 | $1.58 | $1.3K | 2,543,325 | SEC↗ |
| Pisano Wayne | Director | P Buy | 2018-12-28 | 2018-12-31 | 5,000 | $1.80 | $9.0K | 7,500 | SEC↗ |
| Palmer Ashleigh | President and CEO | P Buy | 2018-12-28 | 2018-12-31 | 5,000 | $1.73 | $8.7K | 2,542,500 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2018-12-28 | 2018-12-31 | 10,000 | $1.76 | $17.6K | 83,712 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2018-12-27 | 2018-12-28 | 20,000 | $1.95 | $39.0K | 73,712 | SEC↗ |
| CATLIN AVERY W | Director | P Buy | 2018-12-26 | 2018-12-27 | 5,000 | $1.85 | $9.3K | 20,000 | SEC↗ |
| CATLIN AVERY W | Director | P Buy | 2018-12-24 | 2018-12-27 | 5,000 | $1.90 | $9.5K | 15,000 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2018-12-24 | 2018-12-27 | 17,270 | $1.92 | $33.2K | 53,712 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2018-12-21 | 2018-12-26 | 2,000 | $1.85 | $3.7K | 36,442 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2018-12-20 | 2018-12-21 | 5,000 | $1.96 | $9.8K | 34,442 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2018-12-03 | 2018-12-06 | 4,442 | $2.45 | $10.9K | 29,442 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2018-11-30 | 2018-12-03 | 4,849 | $2.45 | $11.9K | 25,000 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2018-11-29 | 2018-12-03 | 151 | $2.47 | $373 | 20,151 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2018-11-27 | 2018-11-28 | 10,000 | $2.46 | $24.6K | 20,000 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | P Buy | 2018-11-26 | 2018-11-27 | 10,000 | $2.65 | $26.5K | 10,000 | SEC↗ |
| Drechsler Andrew T | Chief Financial Officer | M Exercise deriv | 2018-11-13 | 2018-11-14 | 10,000 | — | $0 | 531,720 | SEC↗ |
| Drechsler Andrew T | Chief Financial Officer | M Exercise | 2018-11-13 | 2018-11-14 | 10,000 | $2.50 | $25.0K | 16,250 | SEC↗ |
| CATLIN AVERY W | Director | P Buy | 2018-11-09 | 2018-11-13 | 10,000 | $3.15 | $31.5K | 10,000 | SEC↗ |
| CATLIN AVERY W | Director | A Award deriv | 2018-09-05 | 2018-09-05 | 128,981 | — | $0 | 128,981 | SEC↗ |
| DIGIANDOMENICO ANTHONY | Director | A Award deriv | 2018-07-19 | 2018-07-19 | 128,981 | — | $0 | 128,981 | SEC↗ |
| Gray Cameron | Director | A Award deriv | 2018-07-19 | 2018-07-19 | 128,981 | — | $0 | 128,981 | SEC↗ |
| Gray Cameron | Director | C Conversion deriv | 2018-07-19 | 2018-07-19 | 144,824 | — | $0 | 144,824 | SEC↗ |
| Pisano Wayne | Director | A Award deriv | 2018-07-19 | 2018-07-19 | 128,981 | — | $0 | 128,981 | SEC↗ |
| MDB CAPITAL GROUP LLC | 10% Owner | C Conversion deriv | 2018-07-19 | 2018-07-19 | 274,289 | — | $0 | 0 | SEC↗ |
| MDB CAPITAL GROUP LLC | 10% Owner | J Other deriv | 2018-07-19 | 2018-07-19 | 1,596,956 | — | $0 | 1,871,245 | SEC↗ |
| MDB CAPITAL GROUP LLC | 10% Owner | C Conversion deriv | 2018-07-19 | 2018-07-19 | 274,289 | — | $0 | 274,289 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | C Conversion deriv | 2018-07-19 | 2018-07-20 | 2,400,000 | — | $0 | 0 | SEC↗ |
| Gray Cameron | Director | J Other deriv | 2018-07-19 | 2018-07-26 | 504,668 | — | $0 | 504,668 | SEC↗ |
| Ramos Eleanor | Chief Medical Officer & COO | P Buy | 2018-07-19 | 2018-07-19 | 60,000 | $4.00 | $240.0K | 60,000 | SEC↗ |
| Drechsler Andrew T | Chief Financial Officer | P Buy | 2018-07-19 | 2018-07-19 | 6,250 | $4.00 | $25.0K | 6,250 | SEC↗ |
| Leon Francisco | Chief Scientific Officer | P Buy | 2018-07-19 | 2018-07-19 | 37,500 | $4.00 | $150.0K | 2,537,500 | SEC↗ |
| Palmer Ashleigh | President and CEO | P Buy | 2018-07-19 | 2018-07-19 | 37,500 | $4.00 | $150.0K | 2,537,500 | SEC↗ |
| Pisano Wayne | Director | P Buy | 2018-07-19 | 2018-07-19 | 2,500 | $4.00 | $10.0K | 2,500 | SEC↗ |
| Johnson & Johnson Innovation - | 10% Owner | C Conversion | 2018-07-19 | 2018-07-20 | 2,400,000 | — | $0 | 2,400,000 | SEC↗ |
| APPEL PETER A | 10% Owner | C Conversion | 2018-07-19 | 2018-07-26 | 1,200,000 | — | $0 | 1,200,000 | SEC↗ |
| APPEL PETER A | 10% Owner | P Buy | 2018-07-19 | 2018-07-26 | 750,000 | $4.00 | $3.00M | 1,950,000 | SEC↗ |